Failures following initial treatment for uncomplicated malaria: Quinine as second line therapy

Journal of Pediatric Infectious Diseases

Volumn 2, Issue 3, 2007, Pages 121-126

  Kofoed, Poul Erik ^a,b,c   Ursing, Johan ^c   Rodrigues, Amabelia ^a   Rombo, Lars ^a,c,d  

^a Studies of the Epidemiology of Epilepsy in Demographic Surveillance Systems   (Guinea-Bissau)

^b KOLDING HOSPITAL   (Denmark)

^c KAROLINSKA INSTITUTE   (Sweden)

^d Division of Infectious Diseases Thoracic Medicine and Dermatology   (Sweden)

Author keywords

Malaria; Quinine; Treatment failure

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL; ARTEMISIN DERIVATIVE; ARTESUNATE; CHLOROQUINE; FANSIDAR; HEMATIN; MEFLOQUINE; MULTIDRUG RESISTANCE PROTEIN 1; QUININE;

ABDOMINAL PAIN; ABSCESS; BLURRED VISION; CONTINUOUS INFUSION; DIARRHEA; DOSAGE SCHEDULE COMPARISON; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG DOSE COMPARISON; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG ELIMINATION; DRUG FATALITY; DRUG HALF LIFE; DRUG INDUCED HEADACHE; DRUG OVERDOSE; HUMAN; HYPOGLYCEMIA; HYPOTENSION; LARYNX DISORDER; LOW DRUG DOSE; MALARIA; MALARIA CONTROL; MALARIA FALCIPARUM; NAUSEA; PARASITEMIA; PATIENT COMPLIANCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; REVIEW; SINGLE DRUG DOSE; TINNITUS; TREATMENT DURATION; TREATMENT FAILURE; VERTIGO; VOMITING;

EID: 34548763243     PISSN: 13057707     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0035-1557036     Document Type: Review

References (47)

1. B.M. Greenwood, K. Bojang, C.J. Whitty and G.A. Targett, Malaria, Lancet 365 (2005), 1487-1498.
2. P. Olliario, J. Cattani and D. Wirth, Malaria, the submerged disease, JAMA 17 (1997), 230-233.
3. P. Olliaro and P. Bloland, Clinical and public health implications of antimalarial drug resistance, in: Antimalarial Chemotherapy. Mechanism of Action, Resistance, and New Directions in Drug Discovery P.G. Rosenthal and N.J. Totowa, eds, Totowa, New Jersey: Humana Press 2001, pp. 65-83.
4. L. Tilley, P. Loria and M. Foley, Chloroquine and other quinoline antimalarials, in: Antimalarial Chemotherapy. Mechanisms of Action, Resistance, and New Directions in Drug Discovery, P. Rosenthal and N.J. Totowa, eds, Totowa, New Jersey: Humana Press 2001, pp. 87-121.
5. M. Le Jouan, V. Jullien, E. Tetanye et al., Quinine pharmacokinetics and pharmacodynamics in children with malaria caused by Plasmodium falciparum, Antimicrob Agents Chemother 49 (2005), 3658-3662.
6. W.R. Taylor and N.J. White, Antimalarial drug toxicity: A review, Drug Saf 27 (2004), 25-61.
7. P.E. Kofoed, E. Mapaba, F. Lopes, F. Pussick, P. Aaby and L. Rombo, Comparison of 3, 5 and 7 days' treatment with Quinimax for falciparum malaria in Guinea-Bissau, Trans R Soc Trop Med Hyg 91 (1997), 462-464.
8. A. Jaeger, P. Sander, J. Kopferschmitt and F. Flesch, Clinical features and management of poisoning due to antimalarial drugs, Med Toxicol Adverse Drug Exp 2 (1987), 242-273.
9. M. Giboda and M.B. Denis, Response of Kampuchean strains of Plasmodium falciparum to antimalarials: In-vivo assessment of quinine and quinine plus tetracycline; multiple drug resistance in vitro, J Trop Med Hyg 91 (1988), 205-211.
10. M. Henry, I. Diallo, J. Bordes et al., Urban malaria in Dakar, Senegal: chemosusceptibility and genetic diversity of Plasmodium falciparum isolates, Am J Trop Med Hyg 75 (2006), 146-151.
11. B.Y. Nour, I.A. Faragalla, O.K. Saeed and A.A. Mohamadani, In vitro study assessing the response of Plasmodium falciparum malaria to chloroquine, sulfadoxine/pyrimethamine, quinine and mefloquine in Wad Medani District, Sudan, Saudi Med J 27 (2006), 808-812.
12. H.Y. Myint, P. Tipmanee, F. Nosten et al., A systematic overview of published antimalarial drug trials, Trans R Soc Trop Med Hyg 98 (2004), 73-81.
13. P.E. Kofoed, F. Lopes, P. Johansson et al., Low-dose quinine for treatment of Plasmodium falciparum malaria in Guinea-Bissau, Trans R Soc Trop Med Hyg 93 (1999), 547-549.
14. P.E. Kofoed, F. Co, A. Poulsen et al., Treatment of Plasmodium falciparum malaria with quinine in children in Guinea-Bissau: One daily dose is sufficient, Trans R Soc Trop Med Hyg 96 (2002), 185-188.
15. M.T. Ferdig, R.A. Cooper, J. Mu et al., Dissecting the loci of low-level quinine resistance in malaria parasites, Mol Microbiol 52 (2004), 985-997.
16. A.B. Sidhu, A.C. Uhlemann, S.G. Valderramos, J.C. Valderramos, S. Krishna and D.A. Fidock, Decreasing pfmdr1 copy number in Plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin, J Infect Dis 194 (2006), 528-535.
17. M.B. Reed, K.J. Saliba, S.R. Caruana, K. Kirk and A.F. Cowman, Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum, Nature 403 (2000), 906-909.
18. World Health Organization. Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria. Geneva: WHO, 2003.
19. World Health Organization. Susceptibility of Plasmodium falciparum to antimalarial drugs. Report on global monitoring 1996-2004. Geneva: WHO, 2005. Report No. WHO/HTM/MAL/2005.1003.
20. O. Gaye, E.F. Dansokho, O. Faye, M.J.Sene, Y. Dieng and S. Diallo, Evaluation of the treatment of malaria using a 3-day regimen of quinine in Dakar, Med Trop (Mars) 57 (1997), 47-48 (in French)
21. I. Villadary, C. Paquet, E. Hemelsdael, G. Blanchard and Z.M. Saki, In vivo drug sensitivity of Plasmodium falciparum in the Tabou region of Ivory Coast, Bull Soc Pathol Exot 90 (1997), 10-13 (in French).
22. P. Deloron, J.P. Lepers, F. Verdier et al., Efficacy of a 3-day oral regimen of a quinine-quinidine-cinchonine association (Quinimax) for treatment of falciparum malaria in Madagascar, Trans R Soc Trop Med Hyg 83 (1989), 751-754.
23. R. Jambou, B. Abissegue, H. Gelas et al., Uncomplicated attack of malaria in an area with high resistance to chloroquine. I. Evaluation of a short treatment with quinine, Bull Soc Pathol Exot 83 (1990), 46-52 (in French).
24. S.I. Adagu, J.N. Okoyeh, L. Lege-Oguntoye et al., Efficacy of a 3-day oral regimen of quinine in an area of northern Nigeria with low-grade resistance of Plasmodium falciparum to chloroquine and sulphadoxine-pyrimethamine, J Trop Med Hyg 98 (1995), 296-298.
25. J. Roche, A. Benito, S. Ayecaba, C. Amela, R. Molina and J. Alvar, Resistance of Plasmodium falciparum to antimalarial drugs in Equatorial Guinea, Ann Trop Med Parasitol 87 (1993), 443-449.
26. C. Rogier, R. Brau, A. Tall, B. Cisse and J.F. Trape, Reducing the oral quinine-quinidine-cinchonin (Quinimax) treatment of uncomplicated malaria to three days does not increase the recurrence of attacks among children living in a highly endemic area of Senegal, Trans R Soc Trop Med Hyg 90 (1996), 175-178.
27. P.G. Kremsner, S. Winkler, C. Brandts, S. Neifer, U. Bienzle and W. Graninger, Clindamycin in combination with chloroquine or quinine is an effective therapy for uncomplicated Plasmodium falciparum malaria in children from Gabon, J Infect Dis 196 (1994), 467-470.
28. A. Bjorkman, M. Willcox, N. Marbiah and D. Payne, Susceptibility of Plasmodium falciparum to different doses of quinine in vivo and to quinine and quinidine in vitro in relation to chloroquine in Liberia, Bull World Health Organ 69 (1991), 459-465.
29. P.E. Kofoed, F. Co, P. Johansson et al., Treatment of uncomplicated malaria in children in Guinea-Bissau with chloroquine, quinine, and sulfadoxine-pyrimethamine, Trans R Soc Trop Med Hyg 96 (2002), 304-309.
30. G. Di Perri, P. Olliaro, S. Nardi et al., Response of uncomplicated falciparum malaria to oral chloroquine and quinine in Burundi highlands, Acta Trop 70 (1998), 25-33.
31. J. Roche, A. Guerra-Neira, J. Raso and A. Benito, Surveillance of in vivo resistance of Plasmodium falciparum to antimalarial drugs from 1992 to 1999 in Malabo (Equatorial Guinea), Am J Trop Med Hyg 68 (2003), 598-601.
32. N.J. White, Assessment of the pharmacodynamic properties of antimalarial drugs in vivo, Antimicrob Agents Chemother. 41 (1997), 1413-1422.
33. N.J. White, Why is it that antimalarial drug treatments do not always work? Ann Trop Med Parasitol 92 (1998), 449-458.
34. E. Mapaba, U. Hellgren, A. Landberg-Lindgren and L. Rombo, Susceptibility of Plasmodium falciparum to quinine in vitro: effects of drug concentrations and time of exposure, Trans R Soc Trop Med Hyg 89 (1995), 85-89.
35. M.B. van Hensbroek, D. Kwiatkowski, B. van den Berg, F.J. Hoek, C.J. van Boxtel and P.A. Kager, Quinine pharmacokinetics in young children with severe malaria, Am J Trop Med Hyg 54 (1996), 237-242.
36. P.K. Mbudi, N.N. Pela, M.W. Kalonji and M.M. Disu, Comparative efficacy of alternative treatments in Plasmodium falciparum infections in Zaire, Ann Soc Belg Med Trop 69 (1989), 25-33 (in French).
37. M.H. Ibrahim, M.I. Elbashir, A. Naser, I.A. Aelbasit, M.M. Kheir and I. Adam, Low-dose quinine is effective in the treatment of chloroquine-resistant Plasmodium falciparum malaria in eastern Sudan, Ann Trop Med Parasitol 98 (2004), 441-445.
38. P.E. Kofoed, F. Lopez, P. Aaby, K. Hedegaard and L. Rombo, Can mothers be trusted to give malaria treatment to their children at home? Acta Trop 86 (2003), 67-70.
39. E. Depoortere, J.P. Guthmann, N. Sipilanyambe et al., Adherence to the combination of sulphadoxine-pyrimethamine and artesunate in the Maheba refugee settlement, Zambia, Trop Med Int Health 9 (2004), 62-67.
40. F. Smithuis, I. van der Broek, N. Katterman et al., Optimising operational use of artesunate-mefloquine: A randomised comparison of four treatment regimens, Trans R Soc Trop Med Hyg 98 (2004), 182-192.
41. P. Piola, C. Fogg, F. Bajunirwe et al., Supervised versus unsupervised intake of six-dose artemether-lumefantrine for treatment of acute, uncomplicated Plasmodium falciparum malaria in Mbarara, Uganda: A randomised trial, Lancet 365 (2005), 1467-1473.
42. J. K. Baird, Effectiveness of antimalarial drugs, N Engl J Med 352 (2005), 1565-1577.
43. S.A. Eisen, D.K. Miller, R.S. Woodward, E. Spitznagel and T.R. Przybeck, The effect of prescribed daily dose frequency on patient medication compliance, Arch Intern Med 150 (1990), 1881-1884.
44. World Health Organization. Guidelines for the treatment of malaria. Geneva: WHO, 2006.
45. T. Chongsuphajaisiddhi, A. Sabchareon and P. Attanath, Treatment of quinine resistant falciparum malaria in Thai children, Southeast Asian J Trop Med Public Health 14 (1983), 357-362.
46. M.K. Laufer, P.C. Thesing, N.D. Eddington et al., Return of chloroquine antimalarial efficacy in Malawi, N Engl J Med 355 (2006), 1959-1966.
47. J. Ursing, A. Rodrigues and P.E. Kofoed, Chloroquine-resistant malaria in Malawi, N Engl J Med 356 (2007), 868.